Western Oncolytics
Westlake
About Western Oncolytics
Western Oncolytics develops novel therapies for cancer that show promise and demonstrate their value to patients. They expect that their lead technology, a novel immuno-oncolytic therapy, can extend the lives of, or outright cure, patients across a wide range of cancer types while avoiding the severe side effects common with current cancer therapies. Thus, they aim to use the most sophisticated science to give life and hope to cancer patients. Western Oncolytics was incorporated in 2013 and is based in Westlake, Ohio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2015)
- Website: westernoncolytics.com
- Phone: +1 412-435-6730
Industries & Categories
Biotechnology, Health Care, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/western-oncolytics-2690250 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.